Author Correction: EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

Michael Weller¹, Martin van den Bent², Matthias Preusser³, Emilie Le Rhun^{4

5

6

7}, Jörg C Tonn⁸, Giuseppe Minniti⁹, Martin Bendszus¹⁰, Carmen Balana¹¹, Olivier Chinot¹², Linda Dirven^{13

14}, Pim French¹⁵, Monika E Hegi¹⁶, Asgeir S Jakola^{17

18}, Michael Platten^{19

20}, Patrick Roth²¹, Roberta Rudà²², Susan Short²³, Marion Smits²⁴, Martin J B Taphoorn^{13

14}, Andreas von Deimling^{25

26}, Manfred Westphal²⁷, Riccardo Soffietti²², Guido Reifenberger^{28

29}, Wolfgang Wick^{30

31}

Affiliations

¹ Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland. michael.weller@usz.ch.
² Brain Tumor Center at Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands.
³ Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
⁴ Department of Neurosurgery, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.
⁵ University of Lille, U1192, Lille, France.
⁶ Centre Hospitalier Universitaire (CHU) Lille, Neuro-Oncology, General and Stereotaxic Neurosurgery Service, Lille, France.
⁷ Oscar Lambret Center, Neurology, Lille, France.
⁸ Department of Neurosurgery, University Hospital Munich LMU, Munich, Germany.
⁹ Radiation Oncology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy.
¹⁰ Department of Neuroradiology, University Hospital Heidelberg, Heidelberg, Germany.
¹¹ Catalan Institute of Oncology (ICO), Hospital Germans Trias i Pujol, Badalona, Spain.
¹² Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille (APHM), CHU Timone, Department of Neuro-Oncology, Marseille, France.
¹³ Department of Neurology, Leiden University Medical Center, Leiden, Netherlands.
¹⁴ Department of Neurology, Haaglanden Medical Center, The Hague, Netherlands.
¹⁵ Department of Neurology, Erasmus MC, Rotterdam, Netherlands.
¹⁶ Department of Clinical Neurosciences, University Hospital Lausanne, Lausanne, Switzerland.
¹⁷ Department of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden.
¹⁸ Institute of Neuroscience and Physiology, Department of Clinical Neuroscience, Sahlgrenska Academy, Gothenburg, Sweden.
¹⁹ Department of Neurology, Medical Faculty Mannheim, Mannheim Center for Translational Neuroscience (MCTN), Heidelberg University, Mannheim, Germany.
²⁰ German Consortium of Translational Cancer Research (DKTK), Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
²¹ Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.
²² Department of Neuro-Oncology, University Hospital, Turin, Italy.
²³ Leeds Institute of Medical Research, St James's University Hospital, Leeds, UK.
²⁴ Department of Radiology and Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
²⁵ Department for Neuropathology, University Hospital Heidelberg, Heidelberg, Germany.
²⁶ DKTK and Clinical Cooperation Unit Neuropathology, DKFZ, Heidelberg, Germany.
²⁷ Department of Neurosurgery, University Hospital Hamburg, Hamburg, Germany.
²⁸ Department of Neuropathology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
²⁹ DKTK partner site Essen/Düsseldorf, Düsseldorf, Germany.
³⁰ Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
³¹ DKTK and Clinical Cooperation Unit Neurooncology, DKFZ, Heidelberg, Germany.

PMID: 35322237
PMCID: PMC9038523
DOI: 10.1038/s41571-022-00623-3

Published Erratum

Author Correction: EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

Michael Weller et al. Nat Rev Clin Oncol. 2022 May.

. 2022 May;19(5):357-358.

doi: 10.1038/s41571-022-00623-3.

Authors

Affiliations

¹ Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland. michael.weller@usz.ch.
² Brain Tumor Center at Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands.
³ Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
⁴ Department of Neurosurgery, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.
⁵ University of Lille, U1192, Lille, France.
⁶ Centre Hospitalier Universitaire (CHU) Lille, Neuro-Oncology, General and Stereotaxic Neurosurgery Service, Lille, France.
⁷ Oscar Lambret Center, Neurology, Lille, France.
⁸ Department of Neurosurgery, University Hospital Munich LMU, Munich, Germany.
⁹ Radiation Oncology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy.
¹⁰ Department of Neuroradiology, University Hospital Heidelberg, Heidelberg, Germany.
¹¹ Catalan Institute of Oncology (ICO), Hospital Germans Trias i Pujol, Badalona, Spain.
¹² Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille (APHM), CHU Timone, Department of Neuro-Oncology, Marseille, France.
¹³ Department of Neurology, Leiden University Medical Center, Leiden, Netherlands.
¹⁴ Department of Neurology, Haaglanden Medical Center, The Hague, Netherlands.
¹⁵ Department of Neurology, Erasmus MC, Rotterdam, Netherlands.
¹⁶ Department of Clinical Neurosciences, University Hospital Lausanne, Lausanne, Switzerland.
¹⁷ Department of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden.
¹⁸ Institute of Neuroscience and Physiology, Department of Clinical Neuroscience, Sahlgrenska Academy, Gothenburg, Sweden.
¹⁹ Department of Neurology, Medical Faculty Mannheim, Mannheim Center for Translational Neuroscience (MCTN), Heidelberg University, Mannheim, Germany.
²⁰ German Consortium of Translational Cancer Research (DKTK), Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
²¹ Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.
²² Department of Neuro-Oncology, University Hospital, Turin, Italy.
²³ Leeds Institute of Medical Research, St James's University Hospital, Leeds, UK.
²⁴ Department of Radiology and Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
²⁵ Department for Neuropathology, University Hospital Heidelberg, Heidelberg, Germany.
²⁶ DKTK and Clinical Cooperation Unit Neuropathology, DKFZ, Heidelberg, Germany.
²⁷ Department of Neurosurgery, University Hospital Hamburg, Hamburg, Germany.
²⁸ Department of Neuropathology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
²⁹ DKTK partner site Essen/Düsseldorf, Düsseldorf, Germany.
³⁰ Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
³¹ DKTK and Clinical Cooperation Unit Neurooncology, DKFZ, Heidelberg, Germany.

PMID: 35322237
PMCID: PMC9038523
DOI: 10.1038/s41571-022-00623-3

No abstract available

PubMed Disclaimer

Figures

See this image and copyright information in PMC

Erratum for

EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood.
Weller M, van den Bent M, Preusser M, Le Rhun E, Tonn JC, Minniti G, Bendszus M, Balana C, Chinot O, Dirven L, French P, Hegi ME, Jakola AS, Platten M, Roth P, Rudà R, Short S, Smits M, Taphoorn MJB, von Deimling A, Westphal M, Soffietti R, Reifenberger G, Wick W. Weller M, et al. Nat Rev Clin Oncol. 2021 Mar;18(3):170-186. doi: 10.1038/s41571-020-00447-z. Epub 2020 Dec 8. Nat Rev Clin Oncol. 2021. PMID: 33293629 Free PMC article. Review.

Cited by

Looking through the imaging perspective: the importance of imaging necrosis in glioma diagnosis and prognostic prediction - single centre experience.
Ma H, Zeng S, Xie D, Zeng W, Huang Y, Mazu L, Zhu N, Yang Z, Chu J, Zhao J. Ma H, et al. Radiol Oncol. 2024 Feb 21;58(1):23-32. doi: 10.2478/raon-2024-0014. eCollection 2024 Mar 1. Radiol Oncol. 2024. PMID: 38378035 Free PMC article.
Combined inhibition by PRMT5 and MAT2A demonstrates a strong synthetic lethality in MTAP homozygous-deficient glioma models.
Jiang Z, Li X, Xiao Z, Gan W, Zhang X, Zhang Y, Wang W, E Q, Huang Y, Shi Q, Tang Y, Du J, Dong H, Li J, Huang Y. Jiang Z, et al. Cell Death Discov. 2025 May 31;11(1):261. doi: 10.1038/s41420-025-02545-2. Cell Death Discov. 2025. PMID: 40450009 Free PMC article.
Cancer vaccine strategies for the treatment of diffusely infiltrating gliomas.
Jucht A, Dumont S, Pooley C, Gonzalez Castro LN. Jucht A, et al. Ther Adv Vaccines Immunother. 2023 Oct 24;11:25151355231206163. doi: 10.1177/25151355231206163. eCollection 2023. Ther Adv Vaccines Immunother. 2023. PMID: 37886714 Free PMC article. Review.
Maximal Intraoperative 5-Aminolevulinic Acid Fluorescence During Surgical Resection of Multiple Lesions in Multifocal Glioblastoma to Achieve Greater Extent of Resection: A Case Report.
Jacobo JA, Aristizabal J, Cardona-Zorrilla AF. Jacobo JA, et al. Cureus. 2025 Feb 16;17(2):e79083. doi: 10.7759/cureus.79083. eCollection 2025 Feb. Cureus. 2025. PMID: 40104462 Free PMC article.
Mitogen-activated protein kinase kinase kinase 1 facilitates the temozolomide resistance and migration of GBM via the MEK/ERK signalling.
Wu S, Xue S, Tang Y, Zhao W, Zheng M, Cheng Z, Hu X, Sun J, Ren J. Wu S, et al. J Cell Mol Med. 2024 Oct;28(20):e70173. doi: 10.1111/jcmm.70173. J Cell Mol Med. 2024. PMID: 39443331 Free PMC article.

See all "Cited by" articles

Publication types

Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

Affiliations

Author Correction: EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

Authors

Affiliations

Figures

Erratum for

Similar articles

Cited by

Publication types

LinkOut - more resources

Full Text Sources